Trinity Bivalacqua, MD, PhD, addresses updates in high-risk BCG-unresponsive NMIBC treatment presented at ASCO 2024.
EP. 1: UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC
Trinity Bivalacqua, MD, PhD, announces an upcoming UroView series highlighting key information presented at ASCO 2024 surrounding treatment of high-risk BCG-unresponsive NMIBC.
Regulatory recap: FDA approvals in urology from the first half of 2025
Top 10 Urology Times videos from the first half of 2025
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe